E. coli Engineered To Produce Important Class Of Antibiotic, Anti-cancer Drugs

Researchers from the UCLA Henry Samueli School of Engineering and Applied Science have taken a major step forward in the field of metabolic engineering, successfully using the bacterium Escherichia coli to synthesize a class of natural products known bacterial aromatic polyketides, which include important antibiotic and anticancer drugs.

More: continued here

Filed under: Biology on January 4th, 2009